Genome sequencing means figuring out the fundamental order of DNA. This process, which was once very cumbersome and extremely costly, has now reached a tipping point and is becoming commercially viable. While the field of genomics dates pre-1900s, it didn’t start to evolve until the 50s, and in the past few years alone we’ve made huge strides in genetic research aided by new technologies; and all of these advances are leading to more precise identification of genetic mutations, which allows for better preventative measures against diseases. Some popular applications of genome sequencing include:
- Prenatal Testing
- Rare Diseases Testing
- Personalized Medicine
Genome editing ETFs offer promising growth potential to those investors who can stomach to inherent risks with new health care technologies.
Click on the tabs below to see more information on Genome Sequencing ETFs, including historical performance, dividends, holdings, expense ratios, technical indicators, analysts reports and more. Click on an ETF ticker or name to go to its detail page, for in-depth news, financial data and graphs. By default the list is ordered by descending total market capitalization.
As of 11/24/20